Samsung Bioepis Moves Forward With Soliris Rival

Completes Phase III Trial For SB12 Proposed Eculizumab Biosimilar

 
• By Dave Wallace
Eculizumab mab word pink
Samsung Bioepis has completed its Phase III trial for eculizumab • Source: Alamy

More from Biosimilars

More from Products